Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 21, 2012Clinical Cancer Research

Molecular Pathways: Next-Generation Immunotherapy—Inhibiting Programmed Death-Ligand 1 and Programmed Death-1

View Full Paper
Ask AI
Bookmark
Share

Authors

DCDaniel S. ChenSynthetic Genomics (United States)BIBryan IrvingSanofi (United States)F. Stephen HodiF. Stephen HodiUniversité Paris-Sud

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chen et al. (2012) studied this question.

synapsesocial.com/papers/6a16fe3e2fcf950e00058613https://doi.org/10.1158/1078-0432.ccr-12-1362
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clinical significance of B7-H1（PD-L1）expression in human acute leukemia2008 · 121 citations
  2. 2High Resolution Mapping of the Binding Site on Human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and Design of IgG1 Variants with Improved Binding to the FcγR2001 · 1,171 citations